By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Science Briefing

Science Briefing

Science Briefing

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - Today’s Neurology Science Briefing | May 2nd 2026, 9:00:06 am

Medicine

Today’s Neurology Science Briefing | May 2nd 2026, 9:00:06 am

Last updated: May 2, 2026 7:22 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

Key Highlights

•
A new review reveals a strong two-way relationship between the body’s energy molecule NAD+ and the internal circadian clock in dementia, showing this interaction influences sleep and memory loss. This discovery suggests that targeting this pathway with strategies like NAD+ precursors, timed light exposure, and exercise could lead to new treatments for dementia.
Source →

•
A compound found in olive oil, Hydroxytyrosol, was shown to reduce anxiety-like behavior after a traumatic experience in aged mice by boosting the growth of new brain cells in the hippocampus and protecting healthy gut bacteria. This points to a simple, dietary-based approach to potentially increase resilience to stress and post-traumatic stress disorder (PTSD) in older adults.
Source →

•
Researchers discovered that the diabetes drug Vildagliptin protects brain cells in a mouse model of Parkinson’s disease by calming a key inflammatory pathway (NLRP3 inflammasome) and activating a cell survival pathway (PI3K/AKT). This finding highlights a potential new way to repurpose an existing diabetes medication to slow the progression of Parkinson’s disease.
Source →


Stay curious. Stay informed — with
Science Briefing.

Always double check the original article for accuracy.


Reset My Briefings

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Today’s Public Health Science Briefing | May 2nd 2026, 9:00:06 am
Next Article Today’s Clinical Medicine Science Briefing | May 2nd 2026, 9:00:06 am
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

The Built Environment Gets a Boost: A Texas Model for Active Living

Today’s Public Health Science Briefing | March 17th 2026, 1:00:12 pm

Oral dissociative sedation, brought to the doorstep

Rethinking the “Inactive” Carrier: A New Debate on Hepatitis B Treatment

Today’s Neurology Science Briefing | April 4th 2026, 9:00:31 am

Telomeres Tell a Tale: Multiple Sclerosis May Accelerate Biological Ageing in Children

This week’s Medicine Key Highlights

The Synaptic Roots of Drug Tolerance

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Energy
  • Gastroenterology
  • Surgery
  • Natural Language Processing
  • Chemistry
  • Engineering
  • Neurology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?